Amgen v Sanofi ruling: It is time to kiss goodbye to broad, functional patent claims for antibodies March 25, 2021 Auto Bot regulations 0 A US courtâs recent decision to find in favor of Sanofi and invalidate Amgen’s broad antibody patent claims has biotech manufacturers concerned about how to preserve their IP.